Frederic Delobel

Biology Scientist at Ridgeline Therapeutics - Basel, N/A, ch

Frederic Delobel's Contact Details
HQ
N/A
Location
Basel,Basel-Stadt,Switzerland
Company
Ridgeline Therapeutics
Frederic Delobel's Company Details
Ridgeline Therapeutics logo, Ridgeline Therapeutics contact details

Ridgeline Therapeutics

Basel, N/A, ch • 20 - 49 Employees
BioTech/Drugs

Ridgeline Discovery, a Versant Ventures Discovery Engine, creates and operates Versant-financed innovative biotech companies in partnership with entrepreneurs, industry and leading academics across Europe. In recent years, Ridgeline has assembled an international team of >70 highly experienced drug discovery professionals and built and operated several new successful companies, including Black Diamond Therapeutics (NASDAQ: BDTX), Bright Peak Therapeutics and Monte Rosa Therapeutics (NASDAQ: GLUE). Ridgeline is currently expanding its capabilities in Basel to support further company creation efforts in small molecules, biologics, and gene/cell therapy with focus on oncology and immunology.

Biotechnology
Details about Ridgeline Therapeutics
Frequently Asked Questions about Frederic Delobel
Frederic Delobel currently works for Ridgeline Discovery.
Frederic Delobel's role at Ridgeline Discovery is Biology Scientist.
Frederic Delobel's email address is ***@ridgelinediscovery.com. To view Frederic Delobel's full email address, please signup to ConnectPlex.
Frederic Delobel works in the Research industry.
Frederic Delobel's colleagues at Ridgeline Therapeutics are Amelie Wiederkehr, Oliver Horlacher, Thomas Ryckmans, Eve Jakob, Alexander Flohr, Xenia Ioannidou, Melanie Hug and others.
Frederic Delobel's phone number is N/A
See more information about Frederic Delobel